Image

Caregiver Burden in Caregivers of Patients With Multiple Sclerosis

Caregiver Burden in Caregivers of Patients With Multiple Sclerosis

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Individuals aged 18-80 years who have been clinically diagnosed with multiple sclerosis and their caregivers will be included in the study.

Demographic data of the patients, including age, height, weight, and comorbidities, will be recorded. Disease-specific characteristics such as disease duration, presence of incontinence, ambulation status, and presence and severity of pain will be assessed. Functional status of the patients will be evaluated using the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Impact Scale (MSIS). Symptoms related to depression and anxiety in patients will be assessed using the Hospital Anxiety and Depression Scale (HADS).

Subsequently, caregivers of the patients will be evaluated. The severity of insomnia will be assessed using the Insomnia Severity Index (ISI). Symptoms related to anxiety and depression will be evaluated using the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be assessed using the Zarit Caregiver Burden Scale.

Eligibility

Inclusion Criteria:

  • Age 18-80 years
  • Clinically diagnosed with multiple sclerosis by a neurologist
  • Being followed in the physical therapy and rehabilitation clinics during the study period
  • Having a primary or regular caregiver (family member)
  • Both patient and caregiver able to read and understand Turkish and complete questionnaires
  • Willing to participate and provide written informed consent

Exclusion Criteria:

  • Severe cognitive impairment or communication problems preventing questionnaire completion
  • Acute relapse or hospitalization due to exacerbation within the last month
  • Severe comorbid neurological, psychiatric, or systemic disease affecting assessments
  • Caregiver \<18 years old or not providing regular care
  • Paid professional caregiver
  • Caregiver with severe psychiatric, neurological, or primary sleep disorder
  • Refusal to participate

Study details
    Multiple Sclerosis

NCT07549048

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.